Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimum effective dose of sufentanil for tracheal intubation in children
ChiCTR2400080170Phase 4Recruiting
- Sponsor
- Children's Hospital of Chongqing Medical University
- Start
- Jan 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sufentanil (2 arms), sponsored by Children's Hospital of Chongqing Medical University. Primary endpoints: ED50 minimum effective concentration and ED90 minimum effective concentration. Started Jan 2024; status: recruiting.
02
Drugs
sufentanil
Beyond the preview
Go deeper on ChiCTR2400080170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080170.